Phase <scp>II</scp> trial of aflibercept with <scp>FOLFIRI</scp> as a second‐line treatment for Japanese patients with metastatic colorectal cancer

Tadamichi Denda, Takayuki Yoshino, Takeo Sato et al.|Cancer Science|2019

Cited by 39